Kristin Watras, APRN
Women's Health · Phoenix, AZNPI 1619597002
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,219 of the $3,319 with a category attached, or 66.9%. 20 manufacturers reported payments, led by Scynexis, Inc. at 34.8% of the total. Reporting peaked in 2022 at $1,668 and has fallen 68.3% since, to $530 in 2025. Among women's health clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 110 payments — averaging $30.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Scynexis, Inc.$1K
- Sumitomo Pharma America, Inc.$571
- Astellas Pharma US Inc$272
- Organon$232
- AbbVie$203
- Myovant Sciences Inc.$148
- plus $739 from 14 others
What the payments were for
- Consulting fees$1,00030%
- Food & beverage$2,21967%
- Education$1003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Scynexis, Inc. | 3 | $1,155 |
| Sumitomo Pharma America, Inc. | 31 | $571 |
| Astellas Pharma US Inc | 10 | $272 |
| Organon | 12 | $232 |
| AbbVie | 9 | $203 |
| Myovant Sciences Inc. | 10 | $148 |
| Hologic Sales And Service, LLC | 5 | $105 |
| Biogen | 5 | $102 |
| Coopersurgical, Inc. | 6 | $97 |
| Bayer | 4 | $93 |
| Pfizer | 5 | $85 |
| Myriad Women's Health, Inc. | 1 | $76 |
| Mayne Pharma Commercial LLC | 2 | $47 |
| Teleflex LLC | 1 | $30 |
| Aspira Women's Health Inc | 1 | $23 |
| Therapeuticsmd, Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| Gynesonics, Inc. | 1 | $17 |
| Evofem Biosciences, Inc. | 1 | $16 |
| Merck | 1 | $14 |
How this compares
$3,319 in reported general payments places this provider in the 95th percentile of 176 women's health providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 51 | $2,873 |
| ValacyclovirValacyclovir Hcl | 11 | $166 |
| Medroxyprogesterone Acetate | 13 | $120 |
Paid to pharmacies, not to this prescriber.
Other women's health in Phoenix
- Audrey SteinkampPhoenix$3K
- Kimberly SmithPhoenix$2K
- Amy BinegarPhoenix$2K
- Madeline ChelkoPhoenix$2K
- Renee BurkhamPhoenix$2K
- Traci Aldridge InnesPhoenix$2K
- Amber ScrivnerPhoenix$1K
- Dawn HuffPhoenix$1K
- Dawn CopelandPhoenix$1K
- Shelley RosanderPhoenix$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.